missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Fezagepras sodium, MedChemExpress
Description
Fezagepras (Setogepram) sodium acts as an orally active agonist for GPR40 and as an antagonist or inverse agonist for GPR84. Fezagepras sodium decreases renal, liver and pancreatic fibrosis. Fezagepras sodium exerts anti-fibrotic, anti-inflammatory and anti-proliferative actions.
Specifications
Specifications
| Chemical Name or Material | Fezagepras sodium |
| Physical Form | Solid |
| CAS | 1254472-97-3 |
| Color | White |
| Quantity | 100 mg |
| Purity Grade Notes | Research |
| Molecular Formula | C13H17NaO2 |
| For Use With (Application) | COVID-19-immunoregulation |
| Synonym | Setogepram sodiumPBI-4050 sodium |
| Solubility Information | H2O : ≥ 100 mg/mL (438.10 mM) ∣DMSO : ≥ 64 mg/mL (280.38 mM) |
| Show More |
Research purposes only
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?